Mithra Launches Capital Increase by Means of a Private Placement via an Accelerated Bookbuild Offering

Liège, Belgium, 30 May 2018, 16:05 CET – Mithra Pharmaceuticals SA (the “Company” or “Mithra”), a company specialized in Women’s Health (Euronext Brussels: MITRA), announces the launch of a capital increase of approximately EUR 60 million by means of a private placement via an accelerated bookbuild offering (the “Private Placement”), with the possibility to increase the size of the Private Placement to up to 3,880,440 new shares in total (representing up to approximately 11% of the Company’s issued share capital).